Clinical Determinants of Successful Omalizumab Therapy in Severe Allergic Asthma Patients: 4-Year-Long, Real-Life Observation

INTRODUCTION: Omalizumab is a high-cost therapy recommended for the treatment of severe allergic asthma. OBJECTIVE: To find clinical parameters that are related to the sustained response to omalizumab. PATIENTS AND METHODS: This retrospective, real-life, 4-year follow-up was provided in Poland betwe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kucharczyk, Aleksandra, Więsik-Szewczyk, Ewa, Poznańska, Anna, Jahnz-Różyk, Karina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754267/
https://www.ncbi.nlm.nih.gov/pubmed/33363390
http://dx.doi.org/10.2147/JAA.S282203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754267/
https://www.ncbi.nlm.nih.gov/pubmed/33363390
http://dx.doi.org/10.2147/JAA.S282203

Ejemplares similares